Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Suchitrita Rathmann

Showing results (1-10 of 3) with videos related to

Pageof 1
Sort By:
Pharmaceutical Statistics|August 6, 2016
Choosing estimands in clinical trials with missing dataCraig Mallinckrodt, Geert Molenberghs, Suchitrita Rathmann
Clinical Pharmacology and Therapeutics|February 12, 2025
Franchise Data Strategy: "PIVOT"ing From Cognitive Dissonance Toward Making What Is Implicit, ExplicitIndranil Bhattacharya, Suchitrita Rathmann, Safaa Najdi, et al.
Arthritis Research & Therapy|January 31, 2019
Ixekizumab and complete resolution of enthesitis and dactylitis: integrated analysis of two phase 3 randomized trials in psoriatic arthritisDafna D Gladman, Ana-Maria Orbai, Uta Klitz, et al.
Pageof 1

Showing results (1-10 of 3) with videos related to

Sort By:
Pageof 1
Pharmaceutical Statistics|August 6, 2016
Choosing estimands in clinical trials with missing dataCraig Mallinckrodt, Geert Molenberghs, Suchitrita Rathmann
Clinical Pharmacology and Therapeutics|February 12, 2025
Franchise Data Strategy: "PIVOT"ing From Cognitive Dissonance Toward Making What Is Implicit, ExplicitIndranil Bhattacharya, Suchitrita Rathmann, Safaa Najdi, et al.
Arthritis Research & Therapy|January 31, 2019
Ixekizumab and complete resolution of enthesitis and dactylitis: integrated analysis of two phase 3 randomized trials in psoriatic arthritisDafna D Gladman, Ana-Maria Orbai, Uta Klitz, et al.
Pageof 1